An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Expanded access is no longer available for this treatment.
Study NCT00933205
Information provided by Boehringer Ingelheim Pharmaceuticals
First Received on July 3, 2009.
Last Updated on May 18, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
